<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39201991</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>29</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Long COVID Is Not a Functional Neurologic Disorder.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">799</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm14080799</ELocationID><Abstract><AbstractText>Long COVID is a common sequela of SARS-CoV-2 infection. Data from numerous scientific studies indicate that long COVID involves a complex interaction between pathophysiological processes. Long COVID may involve the development of new diagnosable health conditions and exacerbation of pre-existing health conditions. However, despite this rapidly accumulating body of evidence regarding the pathobiology of long COVID, psychogenic and functional interpretations of the illness presentation continue to be endorsed by some healthcare professionals, creating confusion and inappropriate diagnostic and therapeutic pathways for people living with long COVID. The purpose of this perspective is to present a clinical and scientific rationale for why long COVID should not be considered as a functional neurologic disorder. It will begin by discussing the parallel historical development of pathobiological and psychosomatic/sociogenic diagnostic constructs arising from a common root in neurasthenia, which has resulted in the collective understandings of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and functional neurologic disorder (FND), respectively. We will also review the case definition criteria for FND and the distinguishing clinical and neuroimaging findings in FND vs. long COVID. We conclude that considering long COVID as FND is inappropriate based on differentiating pathophysiologic mechanisms and distinguishing clinical findings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Davenport</LastName><ForeName>Todd E</ForeName><Initials>TE</Initials><Identifier Source="ORCID">0000-0001-5772-7727</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, University of the Pacific, Stockton, CA 95211, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Workwell Foundation, Santa Rosa, CA 95403, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blitshteyn</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3982-2031</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, NY 14203, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dysautonomia Clinic, Williamsville, NY 14221, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clague-Baker</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-4513-2889</Identifier><AffiliationInfo><Affiliation>School of Allied Health Professions and Nursing, Institute of Population Health, University of Liverpool, Liverpool L69 7ZX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies-Payne</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0009-0007-3949-799X</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Starship Children's Hospital, Auckland 1023, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Treisman</LastName><ForeName>Glenn J</ForeName><Initials>GJ</Initials><Identifier Source="ORCID">0000-0003-4578-6150</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyson</LastName><ForeName>Sarah F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>School of Health Sciences, University of Manchester, Manchester M14 4PX, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">conversion disorder</Keyword><Keyword MajorTopicYN="N">dysautonomia</Keyword><Keyword MajorTopicYN="N">imaging</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN="N">neurasthenia</Keyword><Keyword MajorTopicYN="N">neurology</Keyword><Keyword MajorTopicYN="N">physical examination</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition (PCC)</Keyword><Keyword MajorTopicYN="N">post-acute sequalae of COVID-19 (PASC)</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>29</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39201991</ArticleId><ArticleId IdType="pmc">PMC11355889</ArticleId><ArticleId IdType="doi">10.3390/jpm14080799</ArticleId><ArticleId IdType="pii">jpm14080799</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beard G. Neurasthenia, or nervous exhaustion. Boston Med. Surg. J. 1869;3:217&#x2013;221. doi: 10.1056/NEJM186904290801301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM186904290801301</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetz C.G. Poor Beard!! Charcot&#x2019;s internationalization of neurasthenia, the &#x201c;American disease&#x201d;. Neurology. 2001;57:510&#x2013;514. doi: 10.1212/WNL.57.3.510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.57.3.510</ArticleId><ArticleId IdType="pubmed">11502922</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I., Davenport T., Wakefield D., Vollmer-Conna U., Cameron B., Vernon S.D., Reeves W.C., Lloyd A., Dubbo Infection Outcomes Study Group Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study. BMJ. 2006;333:575. doi: 10.1136/bmj.38933.585764.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes G.P., Kaplan J.E., Gantz N.M., Komaroff A.L., Schonberger L.B., Straus S.E., Jones J.F., Dubois R.E., Cunningham-Rundles C., Pahwa S., et al. Chronic fatigue syndrome: A working case definition. Ann. Intern. Med. 1988;108:387&#x2013;389. doi: 10.7326/0003-4819-108-3-387.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-108-3-387</ArticleId><ArticleId IdType="pubmed">2829679</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikuta K., Yamada T., Shimomura T., Kuratsune H., Kawahara R., Ikawa S., Ohnishi E., Sokawa Y., Fukushi H., Hirai K., et al. Diagnostic evaluation of 2&#x2032;, 5&#x2032;-oligoadenylate synthetase activities and antibodies against Epstein-Barr virus and Coxiella burnetii in patients with chronic fatigue syndrome in Japan. Microbes Infect. 2003;5:1096&#x2013;1102. doi: 10.1016/j.micinf.2003.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2003.07.002</ArticleId><ArticleId IdType="pubmed">14554250</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimas N.G., Salvato F.R., Morgan R., Fletcher M.A. Immunologic abnormalities in chronic fatigue syndrome. J. Clin. Microbiol. 1990;28:1403&#x2013;1410. doi: 10.1128/jcm.28.6.1403-1410.1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.28.6.1403-1410.1990</ArticleId><ArticleId IdType="pmc">PMC267940</ArticleId><ArticleId IdType="pubmed">2166084</ArticleId></ArticleIdList></Reference><Reference><Citation>Kogelnik A.M., Loomis K., Hoegh-Petersen M., Rosso F., Hischier C., Montoya J.G. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. J. Clin. Virol. 2006;37((Suppl. S1)):S33&#x2013;S38. doi: 10.1016/S1386-6532(06)70009-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(06)70009-9</ArticleId><ArticleId IdType="pubmed">17276366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner A.M., Beqaj S.H., Deeter R.G., Fitzgerald J.T. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. In Vivo. 2004;18:101&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">15113035</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikova E., Reshkova V., Kumanova A., Raleva S., Alexandrova D., Capo N., Murovska M., On Behalf of the European Network on Me/Cfs Euromene Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic encephalomyelitis/chronic fatigue syndrome. J. Med. Virol. 2020;92:3682&#x2013;3688. doi: 10.1002/jmv.25744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25744</ArticleId><ArticleId IdType="pmc">PMC7687071</ArticleId><ArticleId IdType="pubmed">32129496</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasimir F., Toomey D., Liu Z., Kaiping A.C., Ariza M.E., Prusty B.K. Tissue specific signature of HHV-6 infection in ME/CFS. Front. Mol. Biosci. 2022;9:1044964. doi: 10.3389/fmolb.2022.1044964.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.1044964</ArticleId><ArticleId IdType="pmc">PMC9795011</ArticleId><ArticleId IdType="pubmed">36589231</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar J.J., Curns A.T., Welburg L., Jones J.F., Lundgren L.M., Capuron L., Pape J., Reeves W.C., Campbel G.L. Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J. Neuropsychol. 2008;2:477&#x2013;499. doi: 10.1348/174866407X218312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1348/174866407X218312</ArticleId><ArticleId IdType="pubmed">19824176</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevail III Study Group. Sneller M.C., Reilly C., Badio M., Bishop R.J., Eghrari A.O., Moses S.J., Johnson K.L., Gayedyu-Dennis D., Hensley L.E., et al. A longitudinal study of Ebola sequelae in Liberia. N. Engl. J. Med. 2019;380:924&#x2013;934. doi: 10.1056/NEJMoa1805435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1805435</ArticleId><ArticleId IdType="pmc">PMC6478393</ArticleId><ArticleId IdType="pubmed">30855742</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly J.D., Van Ryn C., Badio M., Fayiah T., Johnson K., Gayedyu-Dennis D., Weiser S.D., Porco T.C., Martin J.N., Sneller M.C., et al. Clinical sequelae among individuals with pauci-symptomatic or asymptomatic Ebola virus infection and unrecognised Ebola virus disease in Liberia: A longitudinal cohort study. Lancet Infect. Dis. 2022;22:1163&#x2013;1171. doi: 10.1016/S1473-3099(22)00127-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00127-X</ArticleId><ArticleId IdType="pmc">PMC9329265</ArticleId><ArticleId IdType="pubmed">35588755</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia J.K. The role of enterovirus in chronic fatigue syndrome. J. Clin. Pathol. 2005;58:1126&#x2013;1132. doi: 10.1136/jcp.2004.020255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2004.020255</ArticleId><ArticleId IdType="pmc">PMC1770761</ArticleId><ArticleId IdType="pubmed">16254097</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia J.K., Chia A.Y. Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J. Clin. Pathol. 2008;61:43&#x2013;48. doi: 10.1136/jcp.2007.050054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2007.050054</ArticleId><ArticleId IdType="pubmed">17872383</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledina D., Bradaric N., Milas I., Ivic I., Brncic N., Kuzmicic N. Chronic fatigue syndrome after Q fever. Med. Sci. Monit. 2007;13:CS88&#x2013;CS92.</Citation><ArticleIdList><ArticleId IdType="pubmed">17599032</ArticleId></ArticleIdList></Reference><Reference><Citation>Treib J., Grauer M.T., Haass A., Langenbach J., Holzer G., Woessner R. Chronic fatigue syndrome in patients with Lyme borreliosis. Eur. Neurol. 2000;43:107&#x2013;109. doi: 10.1159/000008144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000008144</ArticleId><ArticleId IdType="pubmed">10686469</ArticleId></ArticleIdList></Reference><Reference><Citation>Fares-Medina S., Diaz-Caro I., Garcia-Montes R., Corral-Liria I., Garcia-Gomez-Heras S. Multiple Chemical Sensitivity Syndrome: First symptoms and evolution of the clinical picture: Case-control study/epidemiological case-control study. Int. J. Environ. Res. Public Health. 2022;19:15891. doi: 10.3390/ijerph192315891.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192315891</ArticleId><ArticleId IdType="pmc">PMC9737200</ArticleId><ArticleId IdType="pubmed">36497963</ArticleId></ArticleIdList></Reference><Reference><Citation>Katerndahl D.A., Bell I.R., Palmer R.F., Miller C.S. Chemical intolerance in primary care settings: Prevalence, comorbidity, and outcomes. Ann. Fam. Med. 2012;10:357&#x2013;365. doi: 10.1370/afm.1346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.1346</ArticleId><ArticleId IdType="pmc">PMC3392295</ArticleId><ArticleId IdType="pubmed">22778124</ArticleId></ArticleIdList></Reference><Reference><Citation>National Academies of Sciences, Engineering, and Medicine . A Long COVID Definition: A Chronic, Systemic Disease State with Profound Consequences. The National Academies Press; Washington, DC, USA: 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">39110819</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post COVID-19 Condition or long COVID: A meta-analysis and systematic review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat. Med. 2023;29:2347&#x2013;2357. doi: 10.1038/s41591-023-02521-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai M., Xie Y., Topol E.J., Al-Aly Z. Three-year outcomes of post-acute sequelae of COVID-19. Nat. Med. 2024;30:1564&#x2013;1573. doi: 10.1038/s41591-024-02987-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-024-02987-8</ArticleId><ArticleId IdType="pmc">PMC11186764</ArticleId><ArticleId IdType="pubmed">38816608</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai N.A., Richardson C.S. Posttreatment Lyme disease syndrome and myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and comparison of pathogenesis. Chronic Dis. Transl. Med. 2023;9:183&#x2013;190. doi: 10.1002/cdt3.74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cdt3.74</ArticleId><ArticleId IdType="pmc">PMC10497844</ArticleId><ArticleId IdType="pubmed">37711861</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M., Paiva B., Montero-Mateo R., Garcia N., Zabaleta A. Epstein-Barr Virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Front. Immunol. 2021;12:656797. doi: 10.3389/fimmu.2021.656797.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.656797</ArticleId><ArticleId IdType="pmc">PMC8634673</ArticleId><ArticleId IdType="pubmed">34867935</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Katz B.Z., Shiraishi Y., Mears C.J., Im Y., Taylor R. Predictors of post-infectious chronic fatigue syndrome in adolescents. Health Psychol. Behav. Med. 2014;2:41&#x2013;51. doi: 10.1080/21642850.2013.869176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21642850.2013.869176</ArticleId><ArticleId IdType="pmc">PMC3956649</ArticleId><ArticleId IdType="pubmed">24660116</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Dorri J.A. ME/CFS and post-exertional malaise among patients with long COVID. Neurol. Int. 2022;15:1&#x2013;11. doi: 10.3390/neurolint15010001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint15010001</ArticleId><ArticleId IdType="pmc">PMC9844405</ArticleId><ArticleId IdType="pubmed">36648965</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R., DeMars J., Franklin K., Culos-Reed S.N., Weatherald J., Wrightson J.G. Chronic fatigue and postexertional malaise in people living with long COVID: An observational study. Phys. Ther. 2022;102:pzac005. doi: 10.1093/ptj/pzac005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzac005</ArticleId><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon S.D., Hartle M., Sullivan K., Bell J., Abbaszadeh S., Unutmaz D., Bateman L. Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Work. 2023;74:1179&#x2013;1186. doi: 10.3233/WOR-220581.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/WOR-220581</ArticleId><ArticleId IdType="pubmed">36911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Islam M., Conroy K., Cotler J., Torres C., Johnson M., Mabie B. COVID-19 symptoms over time: Comparing long-haulers to ME/CFS. Fatigue. 2021;9:59&#x2013;68. doi: 10.1080/21641846.2021.1922140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2021.1922140</ArticleId><ArticleId IdType="pmc">PMC8411893</ArticleId><ArticleId IdType="pubmed">34484973</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokumasu K., Honda H., Sunada N., Sakurada Y., Matsuda Y., Yamamoto K., Nakano Y., Hasegawa T., Yamamoto Y., Otsuka Y., et al. Clinical characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) diagnosed in patients with long COVID. Medicina. 2022;58:850. doi: 10.3390/medicina58070850.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58070850</ArticleId><ArticleId IdType="pmc">PMC9325226</ArticleId><ArticleId IdType="pubmed">35888568</ArticleId></ArticleIdList></Reference><Reference><Citation>Little J., Higgins M., Palepu R. Long COVID&#x2014;Can we deny a diagnosis without denying a person&#x2019;s reality? Australas. Psychiatry. 2024;32:44&#x2013;46. doi: 10.1177/10398562231222809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10398562231222809</ArticleId><ArticleId IdType="pubmed">38111277</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitch A.G. Neurasthenia, myalgic encephalitis or cryptogenic chronic fatigue syndrome? QJM. 1995;88:447&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pubmed">7648237</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilliam A.G. Epidemiological Study on an Epidemic, Diagnosed as Poliomyelitis, Occurring among the Personnel of Los Angeles County General Hospital during the Summer of 1934. United States Government Printing Office; Washington, DC, USA: 1934.</Citation></Reference><Reference><Citation>Sigurdsson B., Sigurjonsson J., Sigurdsson J.H., Thorkelsson J., Gudmundsson K.R. A disease epidemic in Iceland simulating poliomyelitis. Am. J. Hyg. 1950;52:222&#x2013;238. doi: 10.1093/oxfordjournals.aje.a119421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a119421</ArticleId><ArticleId IdType="pubmed">14771044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsay A.M. Myalgic encephalomyelitis: A baffling syndrome with a tragic aftermath. ME Assoc. J. 1981;153:40&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">6913030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsay A.M. Myalgic Encephalomyelitis and Postviral Fatigue States: The Saga of Royal Free Disease. Gower Medical Publishing; London, UK: 1986.</Citation></Reference><Reference><Citation>Epidemic myalgic encephalomyelitis. Br. Med. J. 1978;1:1436&#x2013;1437. doi: 10.1136/bmj.1.6125.1436-a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.1.6125.1436-a</ArticleId><ArticleId IdType="pmc">PMC1604957</ArticleId><ArticleId IdType="pubmed">647324</ArticleId></ArticleIdList></Reference><Reference><Citation>Evengard B., Schacterle R.S., Komaroff A.L. Chronic fatigue syndrome: New insights and old ignorance. J. Intern. Med. 1999;246:455&#x2013;469. doi: 10.1046/j.1365-2796.1999.00513.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2796.1999.00513.x</ArticleId><ArticleId IdType="pubmed">10583715</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Eisele H., Taylor R.R. Assessing attitudes toward new names for chronic fatigue syndrome. Eval. Health Prof. 2001;24:424&#x2013;435. doi: 10.1177/01632780122034993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01632780122034993</ArticleId><ArticleId IdType="pubmed">11817200</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., Jain A.K., DeMeirleir K.L., Peterson D.L., Klimas N.G., Lerner A.M., Flor-Henry P., Joshi P., Powles A.C., Sherkey J.A., et al. Myalgic encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols. J. Chronic Fatigue Syndr. 2003;1:7&#x2013;115. doi: 10.1300/J092v11n01_02.</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., van de Sande M.I., De Meirleir K.L., Klimas N.G., Broderick G., Mitchell T., Staines D., Powles A.C., Speight N., Vallings R., et al. Myalgic encephalomyelitis: International Consensus Criteria. J. Intern. Med. 2011;270:327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L., Valencia I.J., Garvert D.W., Montoya J.G. Deconstructing post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: A patient-centered, cross-sectional survey. PLoS ONE. 2018;13:e0197811. doi: 10.1371/journal.pone.0197811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0197811</ArticleId><ArticleId IdType="pmc">PMC5983853</ArticleId><ArticleId IdType="pubmed">29856774</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L., Valencia I.J., Garvert D.W., Montoya J.G. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front. Pediatr. 2019;7:12. doi: 10.3389/fped.2019.00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00012</ArticleId><ArticleId IdType="pmc">PMC6370741</ArticleId><ArticleId IdType="pubmed">30805319</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 1994;121:953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Torres-Harding S.R., Carrico A.W., Taylor R.R. Symptom occurrence in persons with chronic fatigue syndrome. Biol. Psychol. 2002;59:15&#x2013;27. doi: 10.1016/S0301-0511(01)00120-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0301-0511(01)00120-X</ArticleId><ArticleId IdType="pubmed">11790441</ArticleId></ArticleIdList></Reference><Reference><Citation>Stussman B., Williams A., Snow J., Gavin A., Scott R., Nath A., Walitt B. Characterization of post-exertional malaise in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Front. Neurol. 2020;11:1025. doi: 10.3389/fneur.2020.01025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.01025</ArticleId><ArticleId IdType="pmc">PMC7530890</ArticleId><ArticleId IdType="pubmed">33071931</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Ness J.M., Stevens S.R., Bateman L., Stiles T.L., Snell C.R. Postexertional malaise in women with chronic fatigue syndrome. J. Womens Health. 2010;19:239&#x2013;244. doi: 10.1089/jwh.2009.1507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2009.1507</ArticleId><ArticleId IdType="pubmed">20095909</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien K.K., Brown D.A., Bergin C., Erlandson K.M., Vera J.H., Avery L., Carusone S.C., Cheung A.M., Goulding S., Harding R., et al. Long COVID and episodic disability: Advancing the conceptualisation, measurement and knowledge of episodic disability among people living with Long COVID&#x2014;Protocol for a mixed-methods study. BMJ Open. 2022;12:e060826. doi: 10.1136/bmjopen-2022-060826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-060826</ArticleId><ArticleId IdType="pmc">PMC8905414</ArticleId><ArticleId IdType="pubmed">35256450</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien K.K., Brown D.A., McDuff K., St Clair-Sullivan N., Solomon P., Chan Carusone S., McCorkell L., Wei H., Goulding S., O&#x2019;Hara M., et al. Conceptualising the episodic nature of disability among adults living with Long COVID: A qualitative study. BMJ Glob. Health. 2023;8:e011276. doi: 10.1136/bmjgh-2022-011276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2022-011276</ArticleId><ArticleId IdType="pmc">PMC9979585</ArticleId><ArticleId IdType="pubmed">36863719</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpe M.C., Archard L.C., Banatvala J.E., Borysiewicz L.K., Clare A.W., David A., Edwards R.H., Hawton K.E., Lambert H.P., Lane R.J., et al. A report&#x2013;chronic fatigue syndrome: Guidelines for research. J. R. Soc. Med. 1991;84:118&#x2013;121. doi: 10.1177/014107689108400224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/014107689108400224</ArticleId><ArticleId IdType="pmc">PMC1293107</ArticleId><ArticleId IdType="pubmed">1999813</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves W.C., Wagner D., Nisenbaum R., Jones J.F., Gurbaxani B., Solomon L., Papanicolaou D.A., Unger E.R., Vernon S.D., Heim C. Chronic fatigue syndrome&#x2014;A clinically empirical approach to its definition and study. BMC Med. 2005;3:19. doi: 10.1186/1741-7015-3-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-3-19</ArticleId><ArticleId IdType="pmc">PMC1334212</ArticleId><ArticleId IdType="pubmed">16356178</ArticleId></ArticleIdList></Reference><Reference><Citation>United States National Academy of Medicine . Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. The National Academies Collection: Reports Funded by National Institutes of Health. NAM; Washington, DC, USA: 2015.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence . Myalgic Encephalomyelitis (or Encephalopathy)/Chronic Fatigue Syndrome: Diagnosis and Management&#x2014;NICE Guideline, No. 206. National Institute for Health and Care Excellence: Guidelines; National Institute for Health and Care Excellence; London, UK: 2021.</Citation></Reference><Reference><Citation>A new clinical entity? Lancet. 1956;270:789&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">13320887</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death Based on the Recommendations of the Eighth Revision Conference. 8th ed. World Health Organization; Geneva, Switzerland: 1969.</Citation></Reference><Reference><Citation>World Health Organization . ICD-11: International Classification of Diseases, 11th revision. World Health Organization; Geneva, Switzerland: 2022.</Citation></Reference><Reference><Citation>American Psychiatric Association . Mental Disorders. Diagnostic and Statistical Manual; American Psychiatric Association; Washington, DC, USA: 1952. Committee on Nomenclature and Statistics.</Citation></Reference><Reference><Citation>American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 2nd ed. American Psychiatric Association; Washington, DC, USA: 1968. Committee on Nomenclature and Statistics.</Citation></Reference><Reference><Citation>American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. American Psychiatric Association; Washington, DC, USA: 1980.</Citation></Reference><Reference><Citation>Owens C., Dein S. Conversion disorder: The modern hysteria. Adv. Psychiatr. Treat. 2006;12:152&#x2013;157. doi: 10.1192/apt.12.2.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/apt.12.2.152</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; Arlington, VA, USA: 2013.</Citation></Reference><Reference><Citation>American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR. 5th ed., text revision ed. American Psychiatric Association Publishing; Washington, DC, USA: 2022.</Citation></Reference><Reference><Citation>Mayo Clinic  Dissociative Disorders.  [(accessed on 12 October 2023)].  Available online:  https://www.mayoclinic.org/diseases-conditions/dissociative-disorders/symptoms-causes/syc-20355215.</Citation></Reference><Reference><Citation>Diez I., Williams B., Kubicki M.R., Makris N., Perez D.L. Reduced limbic microstructural integrity in functional neurological disorder. Psychol. Med. 2021;51:485&#x2013;493. doi: 10.1017/S0033291719003386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291719003386</ArticleId><ArticleId IdType="pmc">PMC7247956</ArticleId><ArticleId IdType="pubmed">31769368</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassa T., Spiteri S., Schmidt R., Merkel C., Schoenfeld M.A. Increased amygdala activity associated with cognitive reappraisal strategy in functional neurologic disorder. Front. Psychiatry. 2021;12:613156. doi: 10.3389/fpsyt.2021.613156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.613156</ArticleId><ArticleId IdType="pmc">PMC8032865</ArticleId><ArticleId IdType="pubmed">33841199</ArticleId></ArticleIdList></Reference><Reference><Citation>Ospina J.P., Jalilianhasanpour R., Perez D.L. The role of the anterior and midcingulate cortex in the neurobiology of functional neurologic disorder. Handb. Clin. Neurol. 2019;166:267&#x2013;279. doi: 10.1016/B978-0-444-64196-0.00014-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-64196-0.00014-5</ArticleId><ArticleId IdType="pmc">PMC7012371</ArticleId><ArticleId IdType="pubmed">31731915</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez D.L., Matin N., Williams B., Tanev K., Makris N., LaFrance W.C., Jr., Dickerson B.C. Cortical thickness alterations linked to somatoform and psychological dissociation in functional neurological disorders. Hum. Brain Mapp. 2018;39:428&#x2013;439. doi: 10.1002/hbm.23853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.23853</ArticleId><ArticleId IdType="pmc">PMC5747307</ArticleId><ArticleId IdType="pubmed">29080235</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez D.L., Williams B., Matin N., LaFrance W.C., Jr., Costumero-Ramos V., Fricchione G.L., Sepulcre J., Keshavan M.S., Dickerson B.C. Corticolimbic structural alterations linked to health status and trait anxiety in functional neurological disorder. J. Neurol. Neurosurg. Psychiatry. 2017;88:1052&#x2013;1059. doi: 10.1136/jnnp-2017-316359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316359</ArticleId><ArticleId IdType="pubmed">28844071</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams B., Jalilianhasanpour R., Matin N., Fricchione G.L., Sepulcre J., Keshavan M.S., LaFrance W.C., Jr., Dickerson B.C., Perez D.L. Individual differences in corticolimbic structural profiles linked to insecure attachment and coping styles in motor functional neurological disorders. J. Psychiatr. Res. 2018;102:230&#x2013;237. doi: 10.1016/j.jpsychires.2018.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2018.04.006</ArticleId><ArticleId IdType="pmc">PMC6005758</ArticleId><ArticleId IdType="pubmed">29702433</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutkin M., McLean L., Brown R., Kanaan R.A. Systematic review of psychotherapy for adults with functional neurological disorder. J. Neurol. Neurosurg. Psychiatry. 2020 doi: 10.1136/jnnp-2019-321926. Online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-321926</ArticleId><ArticleId IdType="pubmed">33154184</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone J., LaFrance W.C., Jr., Levenson J.L., Sharpe M. Issues for DSM-5: Conversion disorder. Am. J. Psychiatry. 2010;167:626&#x2013;627. doi: 10.1176/appi.ajp.2010.09101440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2010.09101440</ArticleId><ArticleId IdType="pubmed">20516161</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone J., Hoeritzauer I., McWhirter L., Carson A. Functional neurological disorder: Defying dualism. World Psychiatry. 2024;23:53&#x2013;54. doi: 10.1002/wps.21151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.21151</ArticleId><ArticleId IdType="pmc">PMC10785980</ArticleId><ArticleId IdType="pubmed">38214630</ArticleId></ArticleIdList></Reference><Reference><Citation>McLoughlin C., Hoeritzauer I., Cabreira V., Aybek S., Adams C., Alty J., Ball H.A., Baker J., Bullock K., Burness C., et al. Functional neurological disorder is a feminist issue. J. Neurol. Neurosurg. Psychiatry. 2023;94:855&#x2013;862. doi: 10.1136/jnnp-2022-330192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2022-330192</ArticleId><ArticleId IdType="pmc">PMC10511956</ArticleId><ArticleId IdType="pubmed">36977553</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone J., Carson A., Sharpe M. Functional symptoms and signs in neurology: Assessment and diagnosis. J. Neurol. Neurosurg. Psychiatry. 2005;76((Suppl. S1)):i2&#x2013;i12. doi: 10.1136/jnnp.2004.061655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2004.061655</ArticleId><ArticleId IdType="pmc">PMC1765681</ArticleId><ArticleId IdType="pubmed">15718217</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence  Suspected Neurological Conditions: Recognition and Referral|NICE Guideline [NG127]  [(accessed on 12 October 2023)].  Available online:  https://www.nice.org.uk/guidance/ng127.</Citation><ArticleIdList><ArticleId IdType="pubmed">35077087</ArticleId></ArticleIdList></Reference><Reference><Citation>ME Association  ME Association Petition: M.E. is Not a Functional Disorder. 27 September 2017.  [(accessed on 12 October 2023)].  Available online:  https://meassociation.org.uk/2017/09/me-association-petition-m-e-is-not-a-functional-disorder-27-september-2017/</Citation></Reference><Reference><Citation>Anonymous  The On-Call Doctor Rejected Line&#x2019;s Desperate Call Just Days before Her Husband&#x2019;s Death: &#x2018;He Was Let Down by the System&#x2019;.  [(accessed on 12 October 2023)].  Available online:  https://www-bt-dk.translate.goog/samfund/vagtlaegen-afviste-lines-desperate-opkald-faa-dage-foer-sin-mands-doed-han-blev?_x_tr_sl=da&amp;_x_tr_tl=en&amp;_x_tr_hl=en-US&amp;_x_tr_pto=wapp.</Citation></Reference><Reference><Citation>ME Action  Advocacy Update from Finland.  [(accessed on 12 October 2023)].  Available online:  https://www.meaction.net/2020/12/07/advocacy-update-from-finland/</Citation></Reference><Reference><Citation>American Psychiatric Association . Desk Reference to the Diagnostic Criteria from DSM-5-TR. American Psychiatric Association; Washington, DC, USA: 2022.</Citation></Reference><Reference><Citation>Mishra A., Pandey S. Functional neurological disorders: Clinical spectrum, diagnosis, and treatment. Neurologist. 2022;27:276&#x2013;289. doi: 10.1097/NRL.0000000000000453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NRL.0000000000000453</ArticleId><ArticleId IdType="pubmed">35858632</ArticleId></ArticleIdList></Reference><Reference><Citation>Hira R., Karalasingham K., Baker J.R., Raj S.R. Autonomic manifestations of long-COVID syndrome. Curr. Neurol. Neurosci. Rep. 2023;23:881&#x2013;892. doi: 10.1007/s11910-023-01320-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-023-01320-z</ArticleId><ArticleId IdType="pubmed">37947962</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: Pathophysiological factors and abnormalities of coagulation. Trends Endocrinol. Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Boccatonda A., Campello E., Simion C., Simioni P. Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection. Expert Rev. Hematol. 2023;16:1035&#x2013;1048. doi: 10.1080/17474086.2023.2288154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17474086.2023.2288154</ArticleId><ArticleId IdType="pubmed">38018136</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadja D.M., Mentzer S.J., Fontenay M., Laffan M.A., Ackermann M., Helms J., Jonigk D., Chocron R., Pier G.B., Gendron N., et al. COVID-19 is a systemic vascular hemopathy: Insight for mechanistic and clinical aspects. Angiogenesis. 2021;24:755&#x2013;788. doi: 10.1007/s10456-021-09805-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-021-09805-6</ArticleId><ArticleId IdType="pmc">PMC8238037</ArticleId><ArticleId IdType="pubmed">34184164</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B., Aleman S., Bach K., Boribong B.P., Buggert M., Cherry S., Chertow D.S., Davies H.E., Dupont C.L., et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) Nat. Immunol. 2023;24:1616&#x2013;1627. doi: 10.1038/s41590-023-01601-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01601-2</ArticleId><ArticleId IdType="pubmed">37667052</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K., Peluso M.J., Luo X., Thomas R., Shin M.G., Neidleman J., Andrew A., Young K.C., Ma T., Hoh R., et al. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat. Immunol. 2024;25:218&#x2013;225. doi: 10.1038/s41590-023-01724-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01724-6</ArticleId><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="pubmed">38212464</ArticleId></ArticleIdList></Reference><Reference><Citation>Roe K. A role for T-cell exhaustion in Long COVID-19 and severe outcomes for several categories of COVID-19 patients. J. Neurosci. Res. 2021;99:2367&#x2013;2376. doi: 10.1002/jnr.24917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24917</ArticleId><ArticleId IdType="pmc">PMC8427009</ArticleId><ArticleId IdType="pubmed">34288064</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld M.S., Peluso M.J., Kaveti P., Hill C., Li D., Sander E., Swaminathan S., Arechiga V.M., Lu S., Goldberg S.A., et al. Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary phenotype long coronavirus disease 2019. J. Infect. Dis. 2023;228:542&#x2013;554. doi: 10.1093/infdis/jiad131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiad131</ArticleId><ArticleId IdType="pmc">PMC10686699</ArticleId><ArticleId IdType="pubmed">37166076</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld M.S., Sun K., Tahir P., Peluso M.J., Deeks S.G., Aras M.A., Grandis D.J., Long C.S., Beatty A., Hsue P.Y. Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults: A systematic review and meta-analysis. JAMA Netw. Open. 2022;5:e2236057. doi: 10.1001/jamanetworkopen.2022.36057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.36057</ArticleId><ArticleId IdType="pmc">PMC9557896</ArticleId><ArticleId IdType="pubmed">36223120</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E., Buonsenso D., Carfi A., Malorni W., Long COVID Kids study group Long COVID: An estrogen-associated autoimmune disease? Cell Death Discov. 2021;7:77. doi: 10.1038/s41420-021-00464-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00464-6</ArticleId><ArticleId IdType="pmc">PMC8042352</ArticleId><ArticleId IdType="pubmed">33850105</ArticleId></ArticleIdList></Reference><Reference><Citation>Amiral J., Seghatchian J. Autoimmune complications of COVID-19 and potential consequences for long-lasting disease syndromes. Transfus. Apher. Sci. 2023;62:103625. doi: 10.1016/j.transci.2022.103625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transci.2022.103625</ArticleId><ArticleId IdType="pmc">PMC9757887</ArticleId><ArticleId IdType="pubmed">36585276</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Vojdani E., Saidara E., Maes M. Persistent SARS-CoV-2 Infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in long COVID. Viruses. 2023;15:400. doi: 10.3390/v15020400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020400</ArticleId><ArticleId IdType="pmc">PMC9967513</ArticleId><ArticleId IdType="pubmed">36851614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn P.A., Joseph P., Heerdt P.M., Singh I. Differential cardiopulmonary haemodynamic phenotypes in PASC-related exercise intolerance. ERJ Open Res. 2024;10:00714-2023. doi: 10.1183/23120541.00714-2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00714-2023</ArticleId><ArticleId IdType="pmc">PMC10860209</ArticleId><ArticleId IdType="pubmed">38348243</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Joseph P., Heerdt P.M., Cullinan M., Lutchmansingh D.D., Gulati M., Possick J.D., Systrom D.M., Waxman A.B. Persistent exertional intolerance after COVID-19: Insights from invasive cardiopulmonary exercise testing. Chest. 2022;161:54&#x2013;63. doi: 10.1016/j.chest.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelman B., Charlton B.T., Goulding R.P., Kerkhoff T.J., Breedveld E.A., Noort W., Offringa C., Bloemers F.W., van Weeghel M., Schomakers B.V., et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat. Commun. 2024;15:17. doi: 10.1038/s41467-023-44432-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-44432-3</ArticleId><ArticleId IdType="pmc">PMC10766651</ArticleId><ArticleId IdType="pubmed">38177128</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlpine L., Zubair A.S., Joseph P., Spudich S. Case-control study of individuals with small fiber neuropathy after COVID-19. Neurol. Neuroimmunol. Neuroinflamm. 2024;11:e200244. doi: 10.1212/NXI.0000000000200244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000200244</ArticleId><ArticleId IdType="pmc">PMC11087026</ArticleId><ArticleId IdType="pubmed">38630952</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N., Takeuchi T., Masuoka H., Aoki R., Ishikane M., Iwamoto N., Sugiyama M., Suda W., Nakanishi Y., Terada-Hirashima J., et al. Human gut microbiota and its metabolites impact immune responses in COVID-19 and its complications. Gastroenterology. 2023;164:272&#x2013;288. doi: 10.1053/j.gastro.2022.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.09.024</ArticleId><ArticleId IdType="pmc">PMC9499989</ArticleId><ArticleId IdType="pubmed">36155191</ArticleId></ArticleIdList></Reference><Reference><Citation>United States Centers for Disease Control and Prevention  New ICD-10-CM Code for Post-COVID Conditions, Following the 2019 Novel Coronavirus (COVID-19)  [(accessed on 10 July 2023)]; Available online:  https://www.cdc.gov/nchs/data/icd/announcement-new-icd-code-for-post-covid-condition-april-2022-final.pdf.</Citation></Reference><Reference><Citation>Novakova L., Anyz J., Forejtova Z., Rosikova T., Vechetova G., Sojka P., Ruzicka E., Serranova T. Increased frequency of self-reported obsessive-compulsive symptoms in patients with functional movement disorders. Mov. Disord. Clin. Pract. 2023;10:1341&#x2013;1348. doi: 10.1002/mdc3.13812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.13812</ArticleId><ArticleId IdType="pmc">PMC10525059</ArticleId><ArticleId IdType="pubmed">37772279</ArticleId></ArticleIdList></Reference><Reference><Citation>Roivainen E., Peura M., Patsi J. Cognitive profile in functional disorders. Cogn. Neuropsychiatry. 2023;28:424&#x2013;436. doi: 10.1080/13546805.2023.2275336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13546805.2023.2275336</ArticleId><ArticleId IdType="pubmed">37889124</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton J., Campos R., Creed F. Anxiety, depression and management of medically unexplained symptoms in medical clinics. J. R. Coll. Physicians Lond. 1996;30:18&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5401363</ArticleId><ArticleId IdType="pubmed">8745357</ArticleId></ArticleIdList></Reference><Reference><Citation>Afari N., Ahumada S.M., Wright L.J., Mostoufi S., Golnari G., Reis V., Cuneo J.G. Psychological trauma and functional somatic syndromes: A systematic review and meta-analysis. Psychosom. Med. 2014;76:2&#x2013;11. doi: 10.1097/PSY.0000000000000010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000010</ArticleId><ArticleId IdType="pmc">PMC3894419</ArticleId><ArticleId IdType="pubmed">24336429</ArticleId></ArticleIdList></Reference><Reference><Citation>Teodoro T., Chen J., Gelauff J., Edwards M.J. Functional neurological disorder in people with long COVID: A systematic review. Eur. J. Neurol. 2023;30:1505&#x2013;1514. doi: 10.1111/ene.15721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15721</ArticleId><ArticleId IdType="pubmed">36719069</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett K., Diamond C., Hoeritzauer I., Gardiner P., McWhirter L., Carson A., Stone J. A practical review of functional neurological disorder (FND) for the general physician. Clin. Med. 2021;21:28&#x2013;36. doi: 10.7861/clinmed.2020-0987.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0987</ArticleId><ArticleId IdType="pmc">PMC7850207</ArticleId><ArticleId IdType="pubmed">33479065</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander A.L., Mills A.J., Kelley M., Toran L.S., Smith B., Dalakas M.C., Nath A. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol. Neuroimmunol. Neuroinflamm. 2022;9:e1146. doi: 10.1212/NXI.0000000000001146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemignani F., Bellanova M.F., Saccani E., Pavesi G. Non-length-dependent small fiber neuropathy: Not a matter of stockings and gloves. Muscle Nerve. 2022;65:10&#x2013;28. doi: 10.1002/mus.27379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27379</ArticleId><ArticleId IdType="pubmed">34374103</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen N.W., Stiles L.E., Shaik R., Schneider L., Muppidi S., Tsui C.T., Geng L.N., Bonilla H., Miglis M.G. Characterization of autonomic symptom burden in long COVID: A global survey of 2314 adults. Front. Neurol. 2022;13:1012668. doi: 10.3389/fneur.2022.1012668.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1012668</ArticleId><ArticleId IdType="pmc">PMC9639503</ArticleId><ArticleId IdType="pubmed">36353127</ArticleId></ArticleIdList></Reference><Reference><Citation>Thijs R.D., Brignole M., Falup-Pecurariu C., Fanciulli A., Freeman R., Guaraldi P., Jordan J., Habek M., Hilz M., Traon A.P., et al. Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness: Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN) Clin. Auton. Res. 2021;31:369&#x2013;384. doi: 10.1007/s10286-020-00738-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00738-6</ArticleId><ArticleId IdType="pmc">PMC8184725</ArticleId><ArticleId IdType="pubmed">33740206</ArticleId></ArticleIdList></Reference><Reference><Citation>Panicker J.N., Selai C., Herve F., Rademakers K., Dmochowski R., Tarcan T., von Gontard A., Vrijens D. Psychological comorbidities and functional neurological disorders in women with idiopathic urinary retention: International Consultation on Incontinence Research Society (ICI-RS) 2019. Neurourol. Urodyn. 2020;39((Suppl. S3)):S60&#x2013;S69. doi: 10.1002/nau.24233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nau.24233</ArticleId><ArticleId IdType="pubmed">31782982</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K., Vanichkachorn G., Cheshire W.P., Suarez M.D., Shelly S., Lamotte G.J., Sandroni P., Benarroch E.E., Berini S.E., Cutsforth-Gregory J.K., et al. Autonomic dysfunction following COVID-19 infection: An early experience. Clin. Auton. Res. 2021;31:385&#x2013;394. doi: 10.1007/s10286-021-00803-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>McWhirter L., Ritchie C., Stone J., Carson A. Functional cognitive disorders: A systematic review. Lancet Psychiatry. 2020;7:191&#x2013;207. doi: 10.1016/S2215-0366(19)30405-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(19)30405-5</ArticleId><ArticleId IdType="pubmed">31732482</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M., Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484&#x2013;3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Soung A.L., Vanderheiden A., Nordvig A.S., Sissoko C.A., Canoll P., Mariani M.B., Jiang X., Bricker T., Rosoklija G.B., Arango V., et al. COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis. Brain. 2022;145:4193&#x2013;4201. doi: 10.1093/brain/awac270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac270</ArticleId><ArticleId IdType="pmc">PMC9452175</ArticleId><ArticleId IdType="pubmed">36004663</ArticleId></ArticleIdList></Reference><Reference><Citation>Voruz P., Allali G., Benzakour L., Nuber-Champier A., Thomasson M., Jacot de Alc&#xe2;ntara I., Pierce J., Lalive P.H., L&#xf6;vblad K.-O., Braillard O., et al. Long COVID neuropsychological deficits after severe, moderate, or mild infection. Clin. Transl. Neurosci. 2022;6:9. doi: 10.3390/ctn6020009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ctn6020009</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackmon K., Day G.S., Powers H.R., Bosch W., Prabhakaran D., Woolston D., Pedraza O. Neurocognitive screening in patients following SARS-CoV-2 infection: Tools for triage. BMC Neurol. 2022;22:285. doi: 10.1186/s12883-022-02817-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-022-02817-9</ArticleId><ArticleId IdType="pmc">PMC9338515</ArticleId><ArticleId IdType="pubmed">35907815</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch S., Ferrando S.J., Dornbush R., Shahar S., Smiley A., Klepacz L. Screening for brain fog: Is the montreal cognitive assessment an effective screening tool for neurocognitive complaints post-COVID-19? Gen. Hosp. Psychiatry. 2022;78:80&#x2013;86. doi: 10.1016/j.genhosppsych.2022.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2022.07.013</ArticleId><ArticleId IdType="pmc">PMC9359801</ArticleId><ArticleId IdType="pubmed">35930974</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J.R., Dhodapkar R.M., Lu P., Gehlhausen J.R., Tabachnikova A., Greene K., Tabacof L., Malik A.A., et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623:139&#x2013;148. doi: 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann D.M., Whettlock E.M., Liu S., Arachchillage D.J., Boyton R.J. The immunology of long COVID. Nat. Rev. Immunol. 2023;23:618&#x2013;634. doi: 10.1038/s41577-023-00904-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruffieux H., Hanson A.L., Lodge S., Lawler N.G., Whiley L., Gray N., Nolan T.H., Bergamaschi L., Mescia F., Turner L., et al. A patient-centric modeling framework captures recovery from SARS-CoV-2 infection. Nat. Immunol. 2023;24:349&#x2013;358. doi: 10.1038/s41590-022-01380-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01380-2</ArticleId><ArticleId IdType="pmc">PMC9892000</ArticleId><ArticleId IdType="pubmed">36717723</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina Y., Enose-Akahata Y., Hammoud D.A., Videckis A.J., Narpala S.R., O&#x2019;Connell S.E., Carroll R., Lin B.C., McMahan C.C., Nair G., et al. Deep phenotyping of neurologic postacute sequelae of SARS-CoV-2 infection. Neurol. Neuroimmunol. Neuroinflamm. 2023;10:e200097. doi: 10.1212/NXI.0000000000200097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000200097</ArticleId><ArticleId IdType="pmc">PMC10162706</ArticleId><ArticleId IdType="pubmed">37147136</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp J.A., Reisert M., Dressing A., Gotz V., Kellner E., Mast H., Arndt S., Waller C.F., Wagner D., Rieg S., et al. Cerebral microstructural alterations in Post-COVID-condition are related to cognitive impairment, olfactory dysfunction and fatigue. Nat. Commun. 2024;15:4256. doi: 10.1038/s41467-024-48651-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-48651-0</ArticleId><ArticleId IdType="pmc">PMC11102465</ArticleId><ArticleId IdType="pubmed">38762609</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L., Zhang Z., Liang X., Wang Y., Cao Y., Li M., Zhou F. Glymphatic system dysfunction in recovered patients with mild COVID-19: A DTI-ALPS study. iScience. 2024;27:108647. doi: 10.1016/j.isci.2023.108647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.108647</ArticleId><ArticleId IdType="pmc">PMC10753064</ArticleId><ArticleId IdType="pubmed">38155770</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C., Connolly R., Brennan D., Laffan A., O&#x2019;Keeffe E., Zaporojan L., O&#x2019;Callaghan J., Thomson B., Connolly E., Argue R., et al. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat. Neurosci. 2024;27:421&#x2013;432. doi: 10.1038/s41593-024-01576-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-024-01576-9</ArticleId><ArticleId IdType="pmc">PMC10917679</ArticleId><ArticleId IdType="pubmed">38388736</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaganti J., Poudel G., Cysique L.A., Dore G.J., Kelleher A., Matthews G., Darley D., Byrne A., Jakabek D., Zhang X., et al. Blood brain barrier disruption and glutamatergic excitotoxicity in post-acute sequelae of SARS COV-2 infection cognitive impairment: Potential biomarkers and a window into pathogenesis. Front. Neurol. 2024;15:1350848. doi: 10.3389/fneur.2024.1350848.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2024.1350848</ArticleId><ArticleId IdType="pmc">PMC11097901</ArticleId><ArticleId IdType="pubmed">38756214</ArticleId></ArticleIdList></Reference><Reference><Citation>VanElzakker M.B., Bues H.F., Brusaferri L., Kim M., Saadi D., Ratai E.M., Dougherty D.D., Loggia M.L. Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as assessed by [(11)C]PBR28 PET correlates with vascular disease measures. Brain Behav. Immun. 2024;119:713&#x2013;723. doi: 10.1016/j.bbi.2024.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2024.04.015</ArticleId><ArticleId IdType="pmc">PMC11225883</ArticleId><ArticleId IdType="pubmed">38642615</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Ryder D., Flavell R.R., Wang Y., Levi J., LaFranchi B.H., Deveau T.M., Buck A.M., Munter S.E., Asare K.A., et al. Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection. Sci. Transl. Med. 2024;16:eadk3295. doi: 10.1126/scitranslmed.adk3295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.adk3295</ArticleId><ArticleId IdType="pmc">PMC11337933</ArticleId><ArticleId IdType="pubmed">38959327</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez D.L., Nicholson T.R., Asadi-Pooya A.A., Begue I., Butler M., Carson A.J., David A.S., Deeley Q., Diez I., Edwards M.J., et al. Neuroimaging in functional neurological disorder: State of the field and research agenda. Neuroimage Clin. 2021;30:102623. doi: 10.1016/j.nicl.2021.102623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2021.102623</ArticleId><ArticleId IdType="pmc">PMC8111317</ArticleId><ArticleId IdType="pubmed">34215138</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavroudis I., Kazis D., Kamal F.Z., Gurzu I.L., Ciobica A., Padurariu M., Novac B., Iordache A. Understanding Functional Neurological Disorder: Recent insights and diagnostic challenges. Int. J. Mol. Sci. 2024;25:4470. doi: 10.3390/ijms25084470.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25084470</ArticleId><ArticleId IdType="pmc">PMC11050230</ArticleId><ArticleId IdType="pubmed">38674056</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider A., Weber S., Wyss A., Loukas S., Aybek S. BOLD signal variability as potential new biomarker of functional neurological disorders. Neuroimage Clin. 2024;43:103625. doi: 10.1016/j.nicl.2024.103625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2024.103625</ArticleId><ArticleId IdType="pmc">PMC11179625</ArticleId><ArticleId IdType="pubmed">38833899</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer C.W., LaFaver K., Limachia G.S., Capitan G., Ameli R., Sinclair S., Epstein S.A., Hallett M., Horovitz S.G. Gray matter differences in patients with functional movement disorders. Neurology. 2018;91:e1870&#x2013;e1879. doi: 10.1212/WNL.0000000000006514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006514</ArticleId><ArticleId IdType="pmc">PMC6260194</ArticleId><ArticleId IdType="pubmed">30305450</ArticleId></ArticleIdList></Reference><Reference><Citation>Begue I., Adams C., Stone J., Perez D.L. Structural alterations in functional neurological disorder and related conditions: A software and hardware problem? Neuroimage Clin. 2019;22:101798. doi: 10.1016/j.nicl.2019.101798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.101798</ArticleId><ArticleId IdType="pmc">PMC6484222</ArticleId><ArticleId IdType="pubmed">31146322</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C., Rowe P.C., Verheugt F.W.A., Visser F.C. Cognitive function declines following orthostatic stress in adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Front. Neurosci. 2020;14:688. doi: 10.3389/fnins.2020.00688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00688</ArticleId><ArticleId IdType="pmc">PMC7332734</ArticleId><ArticleId IdType="pubmed">32670016</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C., Rowe P.C., Verheugt F.W.A., Visser F.C. Numeric rating scales show prolonged post-exertional symptoms after orthostatic testing of adults with myalgic encephalomyelitis/chronic fatigue syndrome. Front. Med. 2020;7:602894. doi: 10.3389/fmed.2020.602894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.602894</ArticleId><ArticleId IdType="pmc">PMC7874746</ArticleId><ArticleId IdType="pubmed">33585505</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C., Rowe P.C., Visser F.C. Cerebral blood flow is reduced in severe myalgic encephalomyelitis/chronic fatigue syndrome patients during mild orthostatic stress testing: An exploratory study at 20 degrees of head-up tilt testing. Healthcare. 2020;8:169. doi: 10.3390/healthcare8020169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8020169</ArticleId><ArticleId IdType="pmc">PMC7349207</ArticleId><ArticleId IdType="pubmed">32545797</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C., Rowe P.C., Visser F.C. Cerebral blood flow remains reduced after tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome patients. Clin. Neurophysiol. Pract. 2021;6:245&#x2013;255. doi: 10.1016/j.cnp.2021.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnp.2021.09.001</ArticleId><ArticleId IdType="pmc">PMC8505270</ArticleId><ArticleId IdType="pubmed">34667909</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C.M.C., Rowe P.C., Visser F.C. Worsening symptoms is associated with larger cerebral blood flow abnormalities during tilt-testing in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Medicina. 2023;59:2153. doi: 10.3390/medicina59122153.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina59122153</ArticleId><ArticleId IdType="pmc">PMC10744908</ArticleId><ArticleId IdType="pubmed">38138257</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Verduzco-Gutierrez M. Long COVID: A major public health issue. Am. J. Phys. Med. Rehabil. 2024 doi: 10.1097/PHM.0000000000002486. Online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000002486</ArticleId><ArticleId IdType="pubmed">38686827</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>